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    The value of nephrectomy for patients with advanced renal cell carcinoma is controversial． The
negative opinion is that nephrectomy has not improved survival rates， and the affirmative one is that
nephrectomy has been beneficial by relieving pain， fever or bleeding， and causing spontaneous regression
of distant metastases． Therefore， we studied the clinical evaluatien of surgical procedure for patients
with advanced renal cell carcinoma，
    Of the 115 patients with renal cell carcinoma， who were admitted to our hospital during the
past 24 years， 100 patients underwent surgery and 15 patients had inoperable canc’er． The cancers
of the 100 patients who underwent nephrectomy were graded from stages 1 to IV according to Robson’s
criteria． Thirty patients had stage 1 cancer， 25 patients had stage II cancer， 19 patients had stage
III cancer and 26 patients had stage IV cancer．
    The results obtained were as follows．
    1） The over－all observed survival rate of the 100 patients who had nephrectomy was 39．70／o at
5 years and 33．70／， at I O years． On one hand， of 15 patients who did not undergo nephrectomy， 11
case＄ were dead within 1 year， J9 cases died between 1 and 3 years， and only one case lived for 5 years．
    2） The observed survival rate of cases with stage 1， II， III， IV cancer was 56．1， 58．0， 14．2 and
30．00／．， respectively？ at 5 years and 49．1， 37．5， 14．2 and 30．PO／，， respectively， at 10 years． The prognosis
after nephrectomY for advaneed renal cell carcihoma was better than was first expected， and the survival
rate at 1 year was better than that of the inoperable patients．
    3） Of the 26 patients ・with stage IV renal cell carcinoma， 2 lived for more than 10’years， and
I had spontaneous regression of bilateral pulmonary metastases． A 57－year－old Japanese male had
had bilateral and multiple pulmonary metastases at nephrectomy， but these lesions disappeared 8
years after the operation．
    It is concluded that nephrectomy for advanced renal cell carcinoma is beneficial because there
were more long－term survivals and spontaneous regression of distant metastases after nephrectomy．
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Stage NO， of cases









1 Confined to kidney
U Perirenal fat involvement
  but oonfined to Gerota’s fascia
皿  Regional lymphnode metastasis
 Renal vein and／or inferior vena
  eava involvement
IV Solitary distant metastasis
 multiple distant metasta＄es
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   Fig． ／． Observed survival rate．
×一× ： 100 cases who underwent nephrectomy．
H ： 15 inoperable cases
    Fig． 2． Observed survival rate
 Q一一一〇：stage I cases（n二30），  x＿× ：stage
II cases（n二25）， o＿＿一◎ ：stage ill cases（n＝・：19），































Fig．3． a） Chest roentgenogram upon nephrectomy
   reveaied bilateral and mhltiple mulmonary
    metastases． b） Metastatic lesions disap－








Fig． 4． Pathohistological finding of case 1 showed
   clear cell carcinoma and low grade
























Fig， 5． Pathohistological finding of case 2 showed
   clear cell carcinoma and low grade
   malignancy
／
Fig． 6． Pathohistological finding of case 3 showed
   granular cell carcinoma and low grade





















































































































分類したところ，stage Iは30例， stage IIは25例，．
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